Most not long ago, it's been discovered that conolidine and the above derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in comparable locations as classical opioid receptors, it binds to a big selection of endogenous opioids. Not like most opioid receptors, this receptor acts as a scavenger https://paulx210dfh3.wikigop.com/user